Humulin 70/30 Insulin (hi-710)

Manufacturer LILLY Active Ingredient Insulin NPH and Insulin Regular (Vials)(IN soo lin N P H & IN soo lin REG yoo ler) Pronunciation HYOO-myoo-lin SEV-en-tee THIR-tee IN-soo-lin
It is used to lower blood sugar in patients with high blood sugar (diabetes).
đŸˇī¸
Drug Class
Antidiabetic agent
đŸ§Ŧ
Pharmacologic Class
Insulin, intermediate-acting; Insulin, short-acting
🤰
Pregnancy Category
Category B
✅
FDA Approved
Oct 1982
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Humulin 70/30 is a type of insulin that helps your body use sugar for energy. It's a mix of two kinds of insulin: one that works quickly (regular insulin) and one that works for a longer time (NPH insulin). This combination helps control your blood sugar throughout the day. It's given as an injection under the skin, usually before meals.
📋

How to Use This Medicine

Proper Use of This Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is administered via injection into the fatty tissue of the skin in the upper arm, thigh, buttocks, or stomach area. If you will be self-administering the injection, your doctor or nurse will instruct you on the proper technique.

Preparing the Medication

Before use, this medication must be mixed according to the instructions provided by your doctor. The solution should appear cloudy and milky when ready for use. Do not use the medication if the solution is clear or contains lumps. Additionally, do not use the medication if powder is stuck to the sides of the container.

Administration Guidelines

Take this medication 30 to 45 minutes before meals. Rotate the injection site with each dose to avoid injecting into the same area repeatedly. Avoid injecting into skin that is thickened, has pits or lumps, or is irritated, tender, bruised, red, scaly, hard, scarred, or has stretch marks. Do not use the medication if the solution is leaking, has particles, or has changed color.

Important Safety Precautions

Do not mix this insulin with other types of insulin or liquids in the same syringe. Dispose of needles and other sharp objects in a designated disposal box. Do not reuse needles or other items. When the disposal box is full, follow local regulations for proper disposal. If you have any questions or concerns, consult your doctor or pharmacist.

Special Considerations

Be aware of the proper procedures to follow if you do not eat as much as usual or skip a meal. This medication is not intended for use in an insulin pump. If you have questions or concerns, discuss them with your doctor. Do not draw the medication into a syringe and store it for future use.

Storage and Disposal

Store unopened containers of this medication in the refrigerator. Do not freeze the medication, and do not use it if it has been frozen.

Missed Dose

If you forget to take a dose, be aware of the proper procedures to follow. If you are unsure about what to do in the event of a missed dose, contact your doctor.
💡

Lifestyle & Tips

  • Always check your blood sugar levels as directed by your doctor.
  • Follow your prescribed diet plan and exercise regularly.
  • Learn proper injection technique and rotate injection sites to prevent skin problems.
  • Never share needles or insulin pens with others.
  • Always have a source of fast-acting sugar (e.g., glucose tablets, juice) readily available to treat low blood sugar.
  • Inform your healthcare provider about all medications, supplements, and herbal products you are taking.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Highly individualized based on patient's metabolic needs, blood glucose monitoring, and lifestyle. Typically administered subcutaneously 30-45 minutes before a meal.

Condition-Specific Dosing:

Type 1 Diabetes: Initial total daily dose often 0.5-1.0 units/kg/day, with 70% given as Humulin 70/30 (e.g., two-thirds before breakfast, one-third before dinner).
Type 2 Diabetes: Initial dose often 0.2-0.6 units/kg/day, or 10-20 units once or twice daily, adjusted based on blood glucose levels.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established (use specific insulin regimens for neonates)
Infant: Dosing highly individualized based on weight and blood glucose. Requires careful titration and monitoring.
Child: Dosing highly individualized based on weight, pubertal status, and blood glucose. Often 0.5-1.0 units/kg/day, adjusted based on monitoring.
Adolescent: Dosing highly individualized, often higher during puberty (up to 1.5 units/kg/day). Adjusted based on blood glucose monitoring.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: May require dose reduction; monitor blood glucose closely.
Moderate: Likely requires dose reduction; monitor blood glucose closely.
Severe: Significant dose reduction likely required; monitor blood glucose closely and frequently.
Dialysis: Insulin requirements may decrease; dose adjustment based on frequent blood glucose monitoring.

Hepatic Impairment:

Mild: May require dose reduction; monitor blood glucose closely.
Moderate: Likely requires dose reduction; monitor blood glucose closely.
Severe: Significant dose reduction likely required; monitor blood glucose closely and frequently.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Insulin lowers blood glucose by stimulating peripheral glucose uptake, especially by skeletal muscle and fat, and by inhibiting hepatic glucose production. It inhibits lipolysis and proteolysis, and enhances protein synthesis. Insulin NPH (Isophane) is an intermediate-acting insulin, and Insulin Regular is a short-acting insulin. The combination provides both rapid onset and prolonged glucose control.
📊

Pharmacokinetics

Absorption:

Bioavailability: Approximately 50-60% (subcutaneous, variable)
Tmax: Insulin Regular: 1.5-3.5 hours; Insulin NPH: 4-12 hours (after subcutaneous injection)
FoodEffect: Not directly affected by food, but meal timing is critical for optimal glucose control due to the rapid action of regular insulin.

Distribution:

Vd: Approximately 0.1 L/kg
ProteinBinding: Low (less than 10%)
CnssPenetration: Limited

Elimination:

HalfLife: Insulin Regular: 1-2 hours; Insulin NPH: 6-8 hours (functional half-life, highly variable)
Clearance: Approximately 0.8-1.2 L/min (total body clearance)
ExcretionRoute: Renal (metabolites)
Unchanged: Less than 2% (renal excretion of unchanged insulin)
âąī¸

Pharmacodynamics

OnsetOfAction: Insulin Regular: 30-60 minutes; Insulin NPH: 2-4 hours
PeakEffect: Insulin Regular: 2-4 hours; Insulin NPH: 6-12 hours
DurationOfAction: Insulin Regular: 6-8 hours; Insulin NPH: 18-24 hours (Humulin 70/30 provides a combined duration of up to 24 hours)
Confidence: Medium

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Some allergic reactions can be life-threatening.
Signs of low potassium levels, including:
+ Muscle pain or weakness
+ Muscle cramps
+ An abnormal heartbeat
Thick skin, pits, or lumps at the injection site
Swelling in the arms or legs
Low blood sugar, which may cause:
+ Dizziness or fainting
+ Blurred vision
+ Mood changes
+ Slurred speech
+ Headache
+ Feeling sleepy or weak
+ Shaking
+ Fast heartbeat
+ Confusion
+ Hunger
+ Sweating
+ Seizures

If you experience any of these symptoms, call your doctor right away. If you have low blood sugar, follow the instructions you have been given, which may include taking glucose tablets, liquid glucose, or some fruit juices.

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people do not experience any side effects or only have mild ones, it is essential to discuss any concerns with your doctor. Contact your doctor or seek medical attention if you experience:

Weight gain
Irritation at the injection site

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Symptoms of low blood sugar (hypoglycemia): sweating, shakiness, dizziness, confusion, hunger, irritability, rapid heartbeat. Treat immediately with fast-acting sugar.
  • Symptoms of high blood sugar (hyperglycemia): increased thirst, frequent urination, fatigue, blurred vision. Contact your doctor if persistent.
  • Signs of allergic reaction: rash, itching, swelling (especially of face/tongue/throat), severe dizziness, trouble breathing. Seek immediate medical attention.
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have low blood sugar (hypoglycemia), as this may affect your treatment plan.

This is not an exhaustive list of potential interactions. To ensure your safety, it is crucial to discuss all of your:

Prescription and over-the-counter (OTC) medications
Natural products
Vitamins
Health problems

with your doctor and pharmacist. They will help you determine whether it is safe to take this medication in combination with your other medications and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

This drug may cause low blood sugar, which can lead to seizures, loss of consciousness, permanent brain damage, and even death if not properly managed. It is crucial to discuss this risk with your doctor. Additionally, this medication may cause low blood potassium levels, which can result in abnormal heart rhythms, severe breathing difficulties, and potentially death if left untreated. If you experience any symptoms, you must consult your doctor.

Until you understand how this medication affects you, avoid driving and other activities that require your full attention. Certain diabetes medications, such as pioglitazone or rosiglitazone, may increase the risk of heart failure or worsen existing heart failure, especially when combined with insulin. If you are taking one of these medications, it is vital to discuss this with your doctor.

To ensure safe use, verify that you have the correct insulin product and are familiar with its administration. Insulin products are available in various containers, including vials, cartridges, and pens. If you have any questions or concerns about measuring or preparing your dose, consult your doctor or pharmacist.

Your ability to control blood sugar levels may be affected during stressful events, such as fever, infection, injury, or surgery. Changes in physical activity, exercise, or diet can also impact blood sugar control.

It is recommended that you wear a medical alert identification to ensure prompt care in case of an emergency. Regularly check your blood sugar levels as instructed by your doctor and undergo blood tests as scheduled.

Do not operate a vehicle if you have experienced low blood sugar, as this increases the risk of accidents. Before consuming alcohol or using products containing alcohol, consult your doctor. Adhere to the diet and exercise plan recommended by your doctor.

To prevent the transmission of infections, do not share your insulin product or any related devices, including pens, cartridge devices, needles, or syringes, with others. This precaution is essential even if the needle has been changed, as you may unknowingly have an infection.

If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. Pregnant or breastfeeding women, or those planning to become pregnant, must discuss the benefits and risks of this medication with their doctor to ensure the best possible outcome for both mother and baby.
🆘

Overdose Information

Overdose Symptoms:

  • Severe hypoglycemia (extremely low blood sugar)
  • Confusion
  • Seizures
  • Loss of consciousness
  • Coma

What to Do:

Immediate treatment of severe hypoglycemia is critical. Administer oral glucose if conscious. If unconscious, administer glucagon injection or intravenous glucose. Call 911 or emergency medical services immediately. Call 1-800-222-1222 for Poison Control.

Drug Interactions

🔴

Major Interactions

  • Beta-blockers (may mask symptoms of hypoglycemia)
  • Thiazolidinediones (TZDs) (increased risk of fluid retention and heart failure when used with insulin)
  • Corticosteroids (may increase blood glucose, requiring higher insulin doses)
  • Diuretics (thiazide and loop diuretics may increase blood glucose)
  • Sympathomimetics (e.g., epinephrine, albuterol, terbutaline - may increase blood glucose)
  • Growth hormone (may increase blood glucose)
🟡

Moderate Interactions

  • Alcohol (may potentiate hypoglycemic effect)
  • Salicylates (e.g., aspirin - may enhance insulin's glucose-lowering effect)
  • Sulfonamide antibiotics (may enhance insulin's glucose-lowering effect)
  • Monoamine oxidase inhibitors (MAOIs) (may enhance insulin's glucose-lowering effect)
  • Angiotensin-converting enzyme (ACE) inhibitors (may enhance insulin's glucose-lowering effect)
  • Somatostatin analogs (e.g., octreotide, lanreotide - may decrease or increase insulin requirements)

Monitoring

đŸ”Ŧ

Baseline Monitoring

HbA1c

Rationale: To establish baseline glycemic control.

Timing: Prior to initiation of therapy.

Fasting Plasma Glucose (FPG)

Rationale: To establish baseline glycemic control.

Timing: Prior to initiation of therapy.

Renal function (SCr, eGFR)

Rationale: Insulin clearance is affected by renal function; dose adjustments may be needed.

Timing: Prior to initiation and periodically thereafter.

Hepatic function (ALT, AST)

Rationale: Insulin metabolism occurs in the liver; dose adjustments may be needed in severe impairment.

Timing: Prior to initiation and periodically thereafter if clinically indicated.

📊

Routine Monitoring

Self-Monitoring Blood Glucose (SMBG)

Frequency: Multiple times daily (e.g., pre-meal, post-meal, bedtime, overnight) depending on patient needs and regimen.

Target: Individualized, typically 80-130 mg/dL pre-meal, <180 mg/dL 1-2 hours post-meal.

Action Threshold: Hypoglycemia (<70 mg/dL) or persistent hyperglycemia (>180-250 mg/dL).

HbA1c

Frequency: Every 3-6 months.

Target: Individualized, typically <7% for most adults.

Action Threshold: Above target range indicates need for therapy adjustment.

Signs and symptoms of hypoglycemia/hyperglycemia

Frequency: Daily, ongoing.

Target: Absence of symptoms.

Action Threshold: Presence of symptoms requires immediate action (e.g., treat hypoglycemia, adjust insulin for hyperglycemia).

Injection site inspection

Frequency: Regularly (e.g., daily/weekly).

Target: Absence of lipodystrophy, redness, swelling.

Action Threshold: Presence of abnormalities requires rotation of sites or medical evaluation.

đŸ‘ī¸

Symptom Monitoring

  • Symptoms of hypoglycemia: sweating, shakiness, dizziness, confusion, hunger, irritability, rapid heartbeat, blurred vision, headache, slurred speech, seizures, unconsciousness.
  • Symptoms of hyperglycemia: increased thirst, increased urination, fatigue, blurred vision, headache, nausea, vomiting, fruity breath odor (ketoacidosis).

Special Patient Groups

🤰

Pregnancy

Insulin is the preferred treatment for diabetes in pregnancy (pre-existing or gestational diabetes) due to its efficacy and safety profile. It does not cross the placenta in significant amounts.

Trimester-Specific Risks:

First Trimester: Insulin requirements may decrease due to nausea/vomiting; careful monitoring needed.
Second Trimester: Insulin requirements typically increase due to hormonal changes and insulin resistance.
Third Trimester: Insulin requirements continue to increase, often peaking in the late third trimester. Close monitoring is essential to prevent fetal complications.
🤱

Lactation

Insulin is considered safe for use during lactation. It is a large protein molecule and is not excreted into breast milk in clinically significant amounts. Insulin requirements may decrease during breastfeeding.

Infant Risk: Low risk to the breastfed infant.
đŸ‘ļ

Pediatric Use

Humulin 70/30 can be used in pediatric patients with diabetes, but dosing is highly individualized based on age, weight, pubertal status, and glycemic control. Careful monitoring and titration are essential due to varying insulin sensitivity and growth spurts.

👴

Geriatric Use

Elderly patients may be at increased risk of hypoglycemia due to impaired renal/hepatic function, reduced food intake, or cognitive impairment. Dosing should be conservative, and blood glucose monitoring should be frequent. Education on hypoglycemia symptoms is crucial.

Clinical Information

💎

Clinical Pearls

  • Humulin 70/30 is a fixed-ratio combination insulin; it cannot be adjusted for individual NPH or Regular components. If more flexibility is needed, separate NPH and Regular insulin vials may be preferred.
  • Always roll the vial gently between palms 10 times and invert 10 times immediately before each injection to ensure the NPH component is evenly suspended.
  • Administer 30-45 minutes before a meal to allow the Regular insulin component to begin working.
  • Patients should be educated on the signs and symptoms of hypoglycemia and how to treat it promptly.
  • Injection sites should be rotated to prevent lipodystrophy (fat accumulation or atrophy) which can affect insulin absorption.
  • Store unopened vials in the refrigerator. Once opened, store at room temperature (below 86°F/30°C) and use within 31 days.
🔄

Alternative Therapies

  • Basal-bolus insulin regimens (e.g., long-acting insulin + rapid-acting insulin with meals)
  • Basal insulin only (e.g., Insulin Glargine, Insulin Detemir)
  • Oral antidiabetic agents (e.g., metformin, sulfonylureas, SGLT2 inhibitors, GLP-1 receptor agonists) for Type 2 Diabetes.
💰

Cost & Coverage

Average Cost: $100 - $300 per 10 mL vial
Insurance Coverage: Tier 2 or Tier 3 (preferred or non-preferred brand-name drug)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about your medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek medical attention. When seeking help, be prepared to provide details about the medication taken, the amount, and the time it happened.